This was most notable in subjects who experienced a clinically significant improvement in depression where they had significant decreases in IL‐6, CRP, and tumor necrosis factor alpha (TNF‐α) compared to those who experienced no improvement in depression. This evidence concerns the gene TNF and depressive symptom measurement.